Wei Eric X, Green Allen, Pepper Jon-Paul, Akkina Sarah R
Division of Facial Plastic and Reconstructive Surgery, Department of Otolaryngology-Head and Neck Surgery, Stanford Health Care, Palo Alto, California, U.S.A.
Department of Otolaryngology-Head and Neck Surgery, University of Utah, Salt Lake City, Utah, U.S.A.
Laryngoscope. 2025 Jun;135(6):2008-2013. doi: 10.1002/lary.31997. Epub 2025 Jan 10.
Incidence data on Facial Nerve Disorders (FND) and Bell's palsy are currently limited. Prior epidemiological studies have estimated the incidence rate of Bell's palsy to be between 11 and 53/100,000 individuals, although the most cited incidence data are from single regions or municipalities, many of which are outdated from several decades ago.
This was a retrospective cohort study of US adults from 2007 to 2022 using the Merative™ Marketscan® Research Databases. Trends in the incidence of FND were described overall and by specific sociodemographic groups, including age, sex, region, and insurance plan type. Chi-squared and simple logistic regression analyses were performed.
From 2007 to 2022, the total adult incidence of all FND was 30.5/100,000, and the total incidence of Bell's palsy alone was 24.5/100,000. Over the study period, there was a significant annual increase of 2.1 cases of FND/100,000 adults (95% Confidence Interval [CI] 1.8, 2.3; p < 0.001), and a significant total increase of 1.5 cases of Bell's palsy/100,000 adults (95% CI 1.2, 1.7; p < 0.001). The total incidence of FND was higher in males (33.1/100,000) than in females (28.4/100,000, p < 0.001), and greater in older age groups (p < 0.001). Additionally, the incidence of FND varied significantly by region (p < 0.001) and insurance plan type (p < 0.001).
This study provides up-to-date incidence rates for Bell's palsy and facial nerve disorders, based on national administrative claims data. Incidence rates of FND and Bell's palsy alone have been increasing in the United States from 2007 to 2022.
3 Laryngoscope, 135:2008-2013, 2025.
目前关于面神经疾病(FND)和贝尔麻痹的发病率数据有限。先前的流行病学研究估计贝尔麻痹的发病率在每10万人中为11至53例,不过最常被引用的发病率数据来自单个地区或城市,其中许多数据已经过时,是几十年前的了。
这是一项使用默克多源数据库(Merative™ Marketscan® Research Databases)对2007年至2022年美国成年人进行的回顾性队列研究。总体上以及按特定社会人口学群体(包括年龄、性别、地区和保险计划类型)描述了FND的发病率趋势。进行了卡方检验和简单逻辑回归分析。
2007年至2022年,所有FND的成年人总发病率为每10万人30.5例,仅贝尔麻痹的总发病率为每10万人24.5例。在研究期间,FND每10万成年人每年显著增加2.1例(95%置信区间[CI] 1.8,2.3;p < 0.001),贝尔麻痹每10万成年人总共显著增加1.5例(95% CI 1.2,1.7;p < 0.001)。FND的总发病率男性(每10万人33.1例)高于女性(每10万人28.4例,p < 0.001),且在老年人群中更高(p < 0.001)。此外,FND的发病率因地区(p < 0.001)和保险计划类型(p < 0.001)而有显著差异。
本研究基于国家行政索赔数据提供了贝尔麻痹和面神经疾病的最新发病率。2007年至2022年美国仅FND和贝尔麻痹的发病率一直在上升。
3 《喉镜》,135:2008 - 2013,2025年